There are 2936 resources available
Live Q&A - 23 September 2020 - 11:30-12:00
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Uncommon EGFR mutations in NSCLC
Presenter: Zofia Piotrowska
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Introduction
Presenter: Luca Quagliata
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Genomic profiling is driving the precision oncology
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Introduction
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Optimizing treatment strategies in first-line mCRC
Presenter: Mark Saunders
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Extending the continuum of care beyond second-line mCRC
Presenter: Timothy Price
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Conclusion
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Looking to the future: How can emerging therapeutic options influence the management landscape?
Presenter: Benjamin Besse
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Live Q&A - 18 September 2020 - 15:30-16:00
Presenter: Pilar Garrido
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast